New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q4 2021 call → NOWe need to determine if management indicates that the economic terms of the newest business have stepped up meaningfully above the company's own recent norm, and that this improvement has only begun to flow into reported results because most of the business in the reported numbers was still written at older, less favorable terms. Let's analyze the transcript. The call is about Q4 2021 earnings. Management discusses record revenues, growth, etc. They talk about future products like AMP-100, MAQ-100, and relaunching IOPIDINE, MAXITROL, MOXEZA. They mention expanding commercial infrastructure, adding sales executives, etc. They talk about investments for future growth. Key points: They mention that they are preparing for approval and launch of AMP-100, and that they expect revenues to more than double in fairly short order when these products get approved. But that is future, not current. They also mention that they are seeing strong daily revenues to this day. But do they indicate that the terms of new business (prices, rates, etc.) have improved versus their own recent past? They talk about growth in units and revenue, but not specifically about pricing or terms improving. They mention that they are adding high-value FDA-approved products to their portfolio, but those are not yet launched. They talk about the potential for AMP-100 to be premium-priced, but that's future. They also mention that they are expanding infrastructure, but that's about costs. The question is about economic terms of the newest business — meaning the deals, orders, contracts, renewals they are currently writing. Do they say that these are at better terms than before? They don't explicitly say that. They talk about revenue growth, but that could be volume, not price. They mention that they are seeing strong daily revenues, but not that pricing has improved. They also mention that they are managing supply chain and increasing inventories, but no mention of price increases. They talk about the base business continuing to grow, but not about better terms. They mention that they expect margins to rise as they launch new products, but that's future. So, there is no indication that the terms of new business have improved versus their own recent past. They don't discuss pricing, rates, spreads, etc. They talk about growth in units and revenue, but not about better economics per unit.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...